Total Payments
$415.06
2023 Payments
$145.71
Companies
15
Transactions
24
Medicare Patients
1,816
Medicare Billing
$77,928
Payment Breakdown by Category
Food & Beverage$415.06 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $415.06 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $59.08 | 3 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $47.28 | 3 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $38.34 | 2 | $0 (2021) |
| Medtronic, Inc. | $36.31 | 2 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $32.53 | 2 | $0 (2021) |
| ARBOR PHARMACEUTICALS, INC. | $28.28 | 2 | $0 (2021) |
| GRT US Holding, Inc. | $25.85 | 2 | $0 (2021) |
| Lundbeck LLC | $23.75 | 1 | $0 (2023) |
| Abbott Laboratories | $22.36 | 1 | $0 (2021) |
| Allergan, Inc. | $19.30 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $145.71 | 8 | Janssen Pharmaceuticals, Inc ($59.08) |
| 2021 | $269.35 | 16 | Collegium Pharmaceutical, Inc. ($47.28) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/21/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, INVEGA | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Neuroscience | ||||||
| 07/19/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/13/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/15/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug), LIVALO | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/01/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Diabetes | ||||||
| 05/09/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: PSYCHIATRY | ||||||
| 05/08/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.75 | General |
| Category: PSYCHIATRY | ||||||
| 06/02/2021 | Abbott Laboratories | Octrode SCS Leads (Device) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Neuromodulation | ||||||
| 04/01/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.64 | General |
| Category: Opioid Analgesic | ||||||
| 03/26/2021 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Pain Management | ||||||
| 03/25/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: PRIMARY CARE | ||||||
| 03/23/2021 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Sleep | ||||||
| 03/22/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.82 | General |
| Category: Opioid Analgesic | ||||||
| 03/16/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: PRIMARY CARE | ||||||
| 03/10/2021 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2021 | Medtronic, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/04/2021 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Chronic Pain | ||||||
| 01/28/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.82 | General |
| Category: Opioid Analgesic | ||||||
| 01/26/2021 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: NEUROSCIENCE | ||||||
| 01/20/2021 | Medtronic, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 01/15/2021 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Pain Management | ||||||
| 01/06/2021 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Sleep | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 220 | 236 | $20,041 | $8,472 |
| 2022 | 9 | 345 | 374 | $43,333 | $20,551 |
| 2021 | 12 | 626 | 717 | $95,864 | $38,687 |
| 2020 | 27 | 625 | 656 | $35,123 | $10,218 |
Total Patients
1,816
Total Services
1,983
Medicare Billing
$77,928
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 50 | 51 | $7,854 | $4,694 | 59.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 43 | 47 | $6,815 | $1,865 | 27.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 33 | 35 | $3,485 | $1,115 | 32.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 23 | 25 | $675.00 | $392.04 | 58.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 14 | 17 | $928.00 | $251.03 | 27.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 38 | 41 | $164.00 | $90.21 | 55.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 19 | 20 | $120.00 | $64.20 | 53.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 139 | 155 | $15,500 | $6,506 | 42.0% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2022 | 59 | 64 | $9,856 | $6,052 | 61.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $6,604 | $2,823 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 25 | $4,200 | $2,034 | 48.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $3,507 | $1,508 | 43.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 14 | $1,740 | $862.60 | 49.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 22 | 24 | $648.00 | $373.90 | 57.7% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 22 | 24 | $1,194 | $344.25 | 28.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 20 | 21 | $84.00 | $46.59 | 55.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 105 | 105 | $26,676 | $11,922 | 44.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 115 | 122 | $21,623 | $7,217 | 33.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 70 | 70 | $11,699 | $5,525 | 47.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 75 | 76 | $15,200 | $4,723 | 31.1% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 96 | 104 | $10,400 | $4,659 | 44.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 34 | $6,087 | $3,054 | 50.2% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 17 | 34 | $934.00 | $550.12 | 58.9% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 50 | 102 | $1,020 | $339.08 | 33.2% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2021 | 21 | 21 | $1,008 | $267.12 | 26.5% |
About Serena Wilson, ARNP
Serena Wilson, ARNP is a Family healthcare provider based in Miami, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2012. The National Provider Identifier (NPI) number assigned to this provider is 1881946259.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Serena Wilson, ARNP has received a total of $415.06 in payments from pharmaceutical and medical device companies, with $145.71 received in 2023. These payments were reported across 24 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($415.06).
As a Medicare-enrolled provider, Wilson has provided services to 1,816 Medicare beneficiaries, totaling 1,983 services with total Medicare billing of $77,928. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Miami, OK
- Active Since 10/10/2012
- Last Updated 09/27/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1881946259
Products in Payments
- XTAMPZA (Drug) $47.28
- NURTEC ODT (Drug) $38.34
- INTELLIS (Device) $36.31
- XARELTO (Drug) $35.44
- AIMOVIG (Biological) $32.53
- Horizant (Drug) $28.28
- Qutenza (Drug) $25.85
- REXULTI (Drug) $23.75
- INVEGA SUSTENNA (Drug) $23.64
- Octrode SCS Leads (Device) $22.36
- UBRELVY (Drug) $19.30
- BELBUCA (Drug) $19.10
- ABILIFY MAINTENA (Drug) $18.09
- BELSOMRA (Drug) $16.96
- SEGLENTIS (Drug) $14.19
- TRULICITY (Drug) $13.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Miami
Yamila Melendez, Arnp, ARNP
Family — Payments: $142,106
Family $142,106
Suzan Rosen, Aprn, APRN
Family — Payments: $107,821
Family $107,821
Mr. Felipe Novoa, Arnp, ARNP
Family — Payments: $80,051
Family $80,051
Dr. Pamela Dudkiewicz, Arnp, ARNP
Family — Payments: $66,729
Family $66,729
Stacy Feemster, Np, NP
Family — Payments: $51,398
Family $51,398
Patrick Szaraz, Fnp, FNP
Family — Payments: $35,665
Family $35,665